SMAD3 and chronic myelogenous leukemia, BCR-ABL1 positive: Because Smad3, a downstream effector of TGF-β signalling, is a ‘master regulator' of cell fate16, it has been of great interest to determine whether Smad3 promotes the maintenance of ‘stemness' in vivo, including CML cell stemness.